Palmar plantar erythrodysesthesia differential diagnosis
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia differential diagnosis |
|
FDA on Palmar plantar erythrodysesthesia differential diagnosis |
|
CDC on Palmar plantar erythrodysesthesia differential diagnosis |
|
Palmar plantar erythrodysesthesia differential diagnosis in the news |
|
Blogs on Palmar plantar erythrodysesthesia differential diagnosis |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
|
Risk calculators and risk factors for Palmar plantar erythrodysesthesia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differential diagnosis
The problem arises in patients after bone marrow transplants, as the clinical and histologic features of PPE can be similar to cutaneous manifestations of acute (first 3 weeks) graft-versus-host disease. It is important to differentiate PPE, which is benign, from the more dangerous graft-versus-host disease. As time progresses, patients with graft-versus-host disease progress to have other body parts affected, while PPE is limited to hands and feet. Serial biopsies every 3 to 5 days can also be helpful in differentiating the two disorders (Crider et al, 1986).